This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe
Estimated IQ of 80 or greater
Between 11-17 years of age
Presence of suicidality
Presence of psychotic disorders
Visual or hearing impairment
Presence of severe depression
NeuroTrainer
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of California, Davis
Collaborator